after subarachnoid hemmrrhage. J Neurosurg.2009;110:1010-1014.
29. Henwood PC, Kennedy TM, Thomson L, Galanis T, Tzanis GL, Merli GJ, et al. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis. J Thromb Thrombolysis.2011;32(2):209-214.
30: Lutz L. Venous thromboembolism in internal medicin: risk assessment and pharmaceutical prophylaxis. Die Med Welt, 2002;53:231-234.
31. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11): 2450 – 2457 .
32. Crowter MA, Cook DJ, Griffith LE, Meade M, Hanna S, Rabbat C et al. Neither baseline test of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical.surgical patients. Intensive Care Med.2005;31(1):48-55.
33. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA. 1990; 263(20):2753-2759.
34. Sostman HD, Stein PD, Gottschalk A, Matta F, Hull R, Goodman L. Acute pulmonary embolism: sensitivity an specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology. 2008; 246(3):941-946.
35. Perrier A, Howarth N, Didier D, Perrier A, Howarth N, Didier D, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med. 2001; 135(2):88-97.
36. Stein PD, Fowler SE, Goodman LR, Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354(22):2317-2327.
37. Perrier A, Nendaz MR, Sarasin FP, Howarth N, Bounameaux H. Cos-effectiviness analysis of diagnostic strategies for suspected pulmonary embolism incluiding helical computed tomography. Am J Resp Crit Care. 2003; 167(1):39-44.
38. Goodman LR, Stein PD, Matta F, Sostman HD, Wakefield TW, Woodard PK, et al. CT venography and compression sonography are diagnosticaly equivalent: data from PIOPED II. Am J Roentgenol. 2007; 189(5):1071-1076.
39. Goodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005; 5: 6-19.
40. Righini M, Perrier A, De Moerloose P, Bounameux H. D-Dimer for venous thromboembolism diagnosis: 20n years later. J Thromb Haemost.2008;6:1059-1071.
41. Tick LW, Ton E, van Voorthuizen T, Hovens MM, Leeuwenburgh I, Lobatto S, et al. Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compresion ultrasonography, and D-dimer test. Am J Med. 2002; 113(8):630-635.
42. Botella FG, Labiós Gomez M, Brasó Aznar JV. Deep vein thrombosis: present and future. Med Clin (Barc).2000;114(15):584-596.
43 Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical patients: validation of a thrombosis risk score. J Thromb Haemost.2004:2:2156-2161.
44. Schönhofer B, Köhler D. Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease. Respiration. 1998; 65(3):173-177.
45. Afzal Beemath A, Stein PD, Skaf A, Al Sibae AR, Alesh I. Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure. Am J Cardiol. 2006; 98(6):793–795.
46. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005; 293(6):715-722.
47. Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost. 2002; 87(6):1076-1077.
48. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006; 24(7):1112-1118.
49. Heit JA. Cancer and venous thromboembolism: scope of the problem. Cancer Control. 2005;12(1 Suppl):5-10.
50. Mahé I, Bergmann JF, d’Azémar P, Vaissie JJ, Caulin C. Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study. Eur J Clin Pharmacol. 2005; 61(5-6):347-351 .
51. Tapson VF, Decousus H, Pini M, Chong BH, Froelich JB, Monreal M, et al; IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: fi ndings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936-945.